Andere Kunden interessierten sich auch für
![Intellectual Property and Development]( "Intellectual Property and Development")
Intellectual Property and Development110,99 €![Intellectual Property and Innovation Management in the Kyrgyz Republic]( "Intellectual Property and Innovation Management in the Kyrgyz Republic")
Intellectual Property and Innovation Management in the Kyrgyz Republic27,99 €![Intellectual Property & Technology Transfer in Brazilian Universities]( "Intellectual Property & Technology Transfer in Brazilian Universities")
Intellectual Property & Technology Transfer in Brazilian Universities48,99 €![Understanding and Profiting from Intellectual Property in International Business]( "Understanding and Profiting from Intellectual Property in International Business")
Understanding and Profiting from Intellectual Property in International Business103,99 €![Intellectual Property Rights Management]( "Intellectual Property Rights Management")
Intellectual Property Rights Management37,99 €![Intellectual Property Rights Management]( "Intellectual Property Rights Management")
Intellectual Property Rights Management81,99 €![Private Equity Exits]( "Private Equity Exits")
Private Equity Exits110,99 €
Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms.
With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. Bridging a widening gap between recent advances in the theory of financial analysis and current challenges faced by pharmaceutical companies, the text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management.
With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. Bridging a widening gap between recent advances in the theory of financial analysis and current challenges faced by pharmaceutical companies, the text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management.